Gilead and Kite Oncology are creating the future of oncology. From antibody-drug conjugates and small molecules to cell therapy-based approaches, our R&D programs and partnerships are creating possibilities for people with overlooked, underserved and difficult-to-treat cancers. We are focused on helping to bring more life to people with cancer and changing the way cancer is treated.